Blue Cross Blue Shield coverage for FDA-approved brand-name GLP-1 medications varies by plan and state. Many plans require prior authorization and BMI documentation. Weight Method offers compounded semaglutide and tirzepatide programs from $199/month as a cash-pay pathway separate from insurance, with licensed providers and direct shipping. Compounded medications are not FDA-approved.
Coverage Details
Most BCBS plans that do cover GLP-1 medications for weight loss require prior authorization with documentation of BMI 30+ (or 27+ with comorbidities), a physician-supervised weight management program of 3-6 months, and medical records supporting the diagnosis. Some BCBS plans cover Wegovy but not Zepbound, or vice versa. Step therapy requirements vary by affiliate. Even approved members often face specialty tier copays ranging from $75-$350 per month, plus annual or lifetime coverage limits. Several BCBS affiliates have added explicit weight loss medication exclusions to employer plans in recent years.
Affordable Alternative
Weight Method provides a consistent, predictable alternative regardless of which BCBS plan you have. At $154/month for semaglutide and $329/month for tirzepatide, every patient gets the same straightforward pricing with no coverage surprises. You avoid the BCBS affiliate lottery entirely and start treatment within days of your medical evaluation.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

